induced constipation who take opioids for the management of chronic non-cancer pain. Movantik is distributed by AstraZeneca ( AZN -0.9% ). Related tickers: ( PGNX -0.2% ) ( SLXP +3.7% ) ( CBST +0.1% ) Post your comment!
Progenics Pharmaceuticals ( PGNX -2.4% ) settles its arbitration with Ono Pharmaceutical Company over Ono's rights to subcutaneous Relistor in Japan and its
By Alexander Maxwell : Having previously updated the investment community in part 3 of my Biotechnology Catalysts series, the purpose of this article is to help give investors an idea of the upcoming biotechnology catalysts through the end of September. It can be hard for investors to be able to ...
Progenics Pharmaceuticals PGNX and partner Wyeth WYE announced Thursday that both the Food and Drug Administration and the European Medicines Agency have accepted
bromide) for treatment of opioid-induced constipation. Salix successfully appealed a CRL that the agency issued on July 27, 2012. Related tickers: (NASDAQ: PGNX ) (NASDAQ: NKTR ) (NYSE: AZN ) (NASDAQ: CBST ) Post your comment!
Progenics Pharmaceuticals (NASDAQ: PGNX ) Q2 2014 Earnings Call August 08, 2014 8:30 am ET ..... Good day, ladies and gentlemen, and welcome to the Progenics Pharmaceuticals Second Quarter 2014 Results Conference Call. [Operator
Progenics Pharmaceuticals (NASDAQ: PGNX ) Q2 results : Revenues: $1.5M (-16.7%); Operating Expenses: $12.6M (-10.6%); Operating Loss: ($11.1M
The following audio is from a conference call that will begin on August 08, 2014 at 08:30 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion. Listen now If you would like to view a transcript of this call, please click here. Complete Story »
Progenics Pharmaceuticals (NASDAQ: PGNX ): Q2 EPS of -$0.17 misses by $0.03 . Revenue of $1.5M (-16.7% Y/Y) misses by $1.33M . Press Release Post your comment!
BAM , BECN , BID , BPL , CCC , CHH , EBIX , ERF , HMSY , HRG , LXU , MGA , MHR , PDCE , PGEM , PGNX , RDNT , SIRO , SUSP , SUSS , TTI Post your comment!